#1 Clinical Trials Search in Europe

Ketamine Hydrochloride

Ketamine Hydrochloride, a versatile anesthetic agent, is being investigated in various clinical trials for its potential therapeutic benefits beyond its traditional use. These studies explore its applications in managing complex regional pain syndrome (CRPS), providing cerebral protection in children undergoing heart surgery, and even as a treatment for anorexia nervosa. This article delves into the ongoing research and potential of Ketamine Hydrochloride in different medical fields.

Table of Contents

What is Ketamine Hydrochloride?

Ketamine Hydrochloride, often simply called ketamine, is a medication primarily used for anesthesia and pain relief. It belongs to a class of drugs known as dissociative anesthetics[1]. Ketamine works by blocking certain receptors in the brain called NMDA receptors, which are involved in pain perception, consciousness, and memory formation[4].

Ketamine is known by several other names, including:

  • Ketalar (a brand name)[4]
  • Ketamine PR (prolonged release form)[3]

Medical Uses of Ketamine

Ketamine has several medical applications, including:

  1. Anesthesia: Ketamine is used as an anesthetic for various surgical procedures, especially in children and in emergency situations[1].
  2. Pain Management: It’s used to treat acute and chronic pain conditions, particularly complex regional pain syndrome (CRPS)[3].
  3. Procedural Sedation: Ketamine can provide sedation for minor medical procedures, especially in pediatric patients[5].
  4. Neuroprotection: Research is being conducted on ketamine’s potential to protect the brain during certain medical procedures, such as heart surgeries in children[4].
  5. Mental Health Treatment: While not explicitly mentioned in the provided studies, ketamine is being researched for its potential in treating depression and other mental health conditions.

How Ketamine is Administered

Ketamine can be administered in several ways, depending on the specific medical situation:

  • Intravenous (IV) Injection: This is the most common method in hospital settings for anesthesia or pain management[2].
  • Intranasal Administration: Ketamine can be given through the nose using a special device. This method is being studied for procedural sedation in children[1][5].
  • Oral Tablets: Prolonged-release oral tablets are being researched for treating chronic pain conditions[3].

Dosage Information

The dosage of ketamine varies widely depending on its use, the patient’s condition, and the route of administration. Some examples from the studies include:

  • For procedural sedation in children: 10mg/kg given intranasally[5].
  • For pain management in CRPS: Oral doses ranging from 80mg to 240mg per day, divided into two doses[3].
  • For anesthesia during surgery: Intravenous doses typically start at 0.5-1.0 mg/kg[2].

It’s crucial to note that ketamine should only be administered under the supervision of a healthcare professional, as the dosage needs to be carefully controlled to ensure safety and effectiveness.

Potential Side Effects and Risks

While ketamine can be an effective medication, it can also cause side effects. Some potential side effects include:

  • Sedation or impaired consciousness
  • Changes in vision (such as double vision or rapid eye movements)
  • Increased heart rate or blood pressure
  • Nausea or vomiting
  • Confusion or disorientation
  • Dizziness or feeling lightheaded
  • Changes in mood or behavior

In rare cases, more serious side effects can occur, such as difficulty breathing or severe allergic reactions. It’s important to inform your healthcare provider immediately if you experience any concerning symptoms[3][4].

Ongoing Research and Future Potential

Several clinical trials are currently exploring new uses and formulations of ketamine:

  • A study is investigating the use of ketamine infusion for brain protection in children undergoing heart surgery[4].
  • Research is being conducted on prolonged-release oral ketamine tablets for treating complex regional pain syndrome[3].
  • The effectiveness of intranasal ketamine for procedural sedation in children is being studied[5].
  • A trial is exploring the effects of ketamine on sleep quality in patients undergoing colonoscopy[4].

These ongoing studies may lead to new approved uses for ketamine in the future, potentially expanding its role in medical treatment.

Study Focus Condition Intervention Key Outcomes
CRPS Pain Management Complex Regional Pain Syndrome Ketamine HCl Prolonged Release Tablets (80mg, 160mg, 240mg) Safety, tolerability, pharmacokinetics, pain reduction
Cerebral Protection in Children Congenital Heart Defects Ketamine infusion (0.1 mg/kg/hour or 0.3 mg/kg/hour) Neuroprotection, brain damage markers
ECG Changes during RIVA QT Interval Variation Lidocaine + Ketamine HCl (0.8 mg/kg) ECG changes, QT and QTc intervals
Sleep Quality in Colonoscopy Sleep Ketamine HCl (0.25-0.50 mg/kg) Sleep quality scores, patient comfort
Pediatric Procedural Sedation Procedural Sedation Intranasal Ketamine (10mg/kg) Successful sedation, procedure completion
Anorexia Nervosa Treatment Anorexia Nervosa Modified Ketogenic Diet + Ketamine infusions Eating disorder symptoms, recovery indicators

FAQ

  • What is Ketamine Hydrochloride being studied for in clinical trials? Ketamine Hydrochloride is being studied for various conditions, including complex regional pain syndrome (CRPS), cerebral protection in children undergoing heart surgery, anesthesia during colonoscopy, procedural sedation in pediatrics, and as a potential treatment for anorexia nervosa.
  • How is Ketamine Hydrochloride administered in these trials? The administration of Ketamine Hydrochloride varies depending on the study. It can be given as oral tablets, intravenous infusions, or intranasally. The dosage and duration of treatment also differ based on the specific trial and condition being studied.
  • What are the potential benefits of using Ketamine Hydrochloride in CRPS? In the CRPS trial, researchers are evaluating the safety, tolerability, and pharmacokinetic profile of Ketamine Hydrochloride prolonged-release tablets. The study aims to explore the drug's potential in managing pain associated with CRPS and its overall efficacy in this condition.
  • Are there any risks or side effects associated with Ketamine Hydrochloride use in these trials? While Ketamine Hydrochloride is being studied for its potential benefits, researchers are also monitoring for possible side effects. These may include sedation, changes in blood pressure, altered mental status, and other effects on various body systems. The trials include safety monitoring and define dose-limiting toxicities to ensure patient safety.
  • How long do these clinical trials typically last? The duration of clinical trials varies. For example, the CRPS study lasts up to 18 weeks, while the anorexia nervosa study follows participants for 12 months. The length of each trial depends on the specific research objectives and the condition being studied.

Ongoing Clinical Trials on Ketamine Hydrochloride

  • Study on the Effects of Opioid-Free Anesthesia with Ketamine Hydrochloride on Oxygen Levels in Patients Undergoing Bariatric Surgery

    Not yet recruiting

    4 1 1 1
    Investigated drugs:
    Spain

  • Ketamine Infusion Study for Symptom Improvement in Patients with Severe Borderline Personality Disorder

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • A study to compare the safety of ketamine hydrochloride and esketamine in healthy men for the treatment of depression

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study Comparing Low-Dose Esketamine and Ketamine for Severe Acute Pain in Emergency Department Patients

    Not recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Study on Ketamine and Magnesium Sulfate for Treating Chronic Cluster Headache in Patients Unresponsive to Standard Treatments

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effects of Propofol Sedation in Preterm Babies with Respiratory Distress Syndrome During LISA Procedure

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Ketamine and Sodium Chloride for Reducing Morphine Use in Patients with Severe Trauma

    Not recruiting

    3 1 1
    Investigated drugs:
    France

  • Study on Psilocybin, Ketamine, and Midazolam for Patients with Treatment-Resistant Depression

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study on the Safety and Pain Relief of Nasal Spray with Ketamine Hydrochloride and Sufentanil Citrate for Children with Moderate to Severe Pain

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Opioid-Free Pain Relief for ICU Patients on Ventilators Using Nefopam Hydrochloride, Paracetamol, and Ketamine Hydrochloride

    Not recruiting

    3 1 1
    Investigated drugs:
    France

Glossary

  • Complex Regional Pain Syndrome (CRPS): A chronic pain condition that usually affects an arm or leg, typically developing after an injury, surgery, stroke, or heart attack. It is characterized by prolonged or excessive pain and changes in skin color, temperature, and/or swelling in the affected area.
  • Pharmacokinetic Profile: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. This helps researchers understand how the body processes the drug and how it affects the body over time.
  • Maximum Tolerated Dose (MTD): The highest dose of a drug that can be given without causing unacceptable side effects. In clinical trials, this is often determined by gradually increasing the dose and monitoring for adverse effects.
  • Dose Limiting Toxicity (DLT): Side effects of a treatment that are severe enough to prevent an increase in dose or require a dose reduction. These are carefully defined and monitored in clinical trials to ensure patient safety.
  • Neuroprotection: The preservation of the structure and function of neurons (brain cells) from damage, degeneration, or death. In the context of the pediatric heart surgery study, it refers to protecting the brain from potential injury during the surgical procedure.
  • Subanesthetic Dose: A dose of an anesthetic drug that is lower than what would typically be used to induce full anesthesia. In some studies, Ketamine is used at these lower doses to achieve specific effects without causing complete sedation.
  • Pittsburgh Sleep Quality Index: A self-reported questionnaire that assesses sleep quality and disturbances over a one-month period. It's used in research to measure the effect of interventions on sleep quality.
  • Modified Ketogenic Diet: A high-fat, low-carbohydrate diet that has been adapted from the traditional ketogenic diet used for epilepsy treatment. In the anorexia nervosa study, it's being investigated as part of a treatment approach.
  • Eating Disorder Examination Questionnaire (EDE-Q): A self-report measure of eating disorder psychopathology based on the Eating Disorder Examination interview. It's used to assess the range and severity of eating disorder features.

References

  1. https://clinicaltrials.gov/study/NCT03290625
  2. https://clinicaltrials.gov/study/NCT02571491
  3. https://clinicaltrials.gov/study/NCT06419985
  4. https://clinicaltrials.gov/study/NCT06525584
  5. https://clinicaltrials.gov/study/NCT03067974